Innovating Mental Health Care: Advancing TMS and Patient Care with Mitchell Ramsey, MGMA Future Five Award Winner

In this episode of the MGMA Insights Podcast, host Daniel Williams sits down with Mitchell Ramsey, CHFP, CRCR, TMS Clinical Coordinator at Psychiatry Associates of Tallahassee and one of MGMA’s 2025 Future Five Award honorees. Mitchell shares how his journey from lacrosse coach to mental health professional shaped his empathetic, patient-first approach to care. He discusses innovations in transcranial magnetic stimulation (TMS) treatment, improving patient intake systems, navigating payer relationships, and the broader movement to destigmatize mental health care.

This episode offers actionable insights for practice leaders looking to improve coordination of care, streamline administrative processes, and strengthen patient engagement.

Episode Takeaways

• (02:58) From Coaching to Caregiving: A Path to Mental Health
  Mitchell describes his unique journey from coaching lacrosse to pursuing mental health care after realizing the power of psychological support in athletic performance.
• (04:56) Inside the TMS Clinic
  He breaks down what transcranial magnetic stimulation (TMS) is — an FDA-approved neuromodulation therapy for depression, OCD, and other conditions — and shares how his small but dedicated team operates within a larger psychiatric practice.
• (07:43) Transforming the Patient Intake & Onboarding Experience
  Mitchell details how he redesigned his clinic’s intake process — shifting from a standardized script to a storytelling-based, empathy-driven approach that helps patients feel understood and supported from the start.
• (09:56) Building Better Payer Relationships
  He explains how open communication and proactive collaboration with insurers reduced prior authorization delays from two to three weeks down to a few days, demonstrating how strong provider–payer relationships improve access to care.
• (11:07) Data-Driven Advocacy for Mental Health
  Mitchell shares how his team’s partnership with BrainsWay, a TMS device manufacturer, has contributed to expanding FDA approval for broader age ranges — underscoring how community practices can influence national treatment accessibility.
• (12:58) Community Partnerships Through NAMI
  Mitchell’s collaboration with the National Alliance on Mental Illness (NAMI) ensures that patients who can’t afford care still receive peer-to-peer mental health support, embodying a comprehensive approach to community wellness.
• (15:33) The Future of Mental Health Care
  He envisions a continued reduction in stigma, deeper integration of mental health across all specialties, and more open acknowledgment of emotional well-being in patient conversations.
• (20:42) Advice for Small Practice Leaders
  Mitchell encourages administrators to remember that “every contribution matters” — reminding listeners that small practices can have large, lasting impacts on the future of healthcare.

Resources Mentioned

• MGMA Future Five Awards - Learn more about MGMA’s program honoring early-career healthcare leaders.
• National Alliance on Mental Illness (NAMI) – Explore peer-to-peer programs and mental health advocacy resources.
• BrainsWay TMS Therapy – Learn about transcranial magnetic stimulation and its FDA-approved uses for depression and OCD.